CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Internet-based guided self-help based on CBT principlesWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (1)

Name (Synonyms) Correlation
D013315 Stress, Psychological NIH 0.21

Correlated HPO Terms (0)

Name (Synonyms) Correlation

There is one clinical trial.

Clinical Trials

1 Pilot Internet-based Self-Help Program for Managing Corona Stress vs. Waitlist Control

The current study examines an adapted guided self-help stress reduction program, focusing on reducing stress in the time of COVID-19. Two studies are planned: 1) an international study in English in which individuals proficient in English throughout the world will participate and 2) a follow-up study in Hebrew.

NCT04394403 Stress Stress, Psychological Behavioral: Internet-based guided self-help based on CBT principles
MeSH:Stress, Psychological

Primary Outcomes

Description: change in a self-report measure of stress during the COVID-19 pandemic that ranges from 0-128. Higher means more symptomatic.

Measure: The CoRonavIruS Health Impact Survey (CRISIS)

Time: change from Pre to post treatment (6 weeks),

Description: change in a self-report measure of stress during the COVID-19 pandemic that ranges from 0-128. Higher means more symptomatic.

Measure: The CoRonavIruS Health Impact Survey (CRISIS)

Time: change from Pre to 6 mos Follow-up

Description: change in a self-report measure of stress during the COVID-19 pandemic that ranges from 0-128. Higher means more symptomatic.

Measure: The CoRonavIruS Health Impact Survey (CRISIS)

Time: change from Pre to 1 year Follow-up

Secondary Outcomes

Description: a self-report measure of depression, anxiety and stress, with each subscale ranging from 0-28. Higher means more symptomatic.

Measure: Depression, Anxiety, and Stress Scale- 21 item version: DASS-21

Time: Weekly change during treatment and at pre and post (6 week) treatment evaluations

Description: a self-report measure of depression, anxiety and stress, with each subscale ranging from 0-28. Higher means more symptomatic.

Measure: Depression, Anxiety, and Stress Scale- 21 item version: DASS-21

Time: change from pre to 6 month follow up

Description: a self-report measure of depression, anxiety and stress, with each subscale ranging from 0-28. Higher means more symptomatic.

Measure: Depression, Anxiety, and Stress Scale- 21 item version: DASS-21

Time: change from pre to 1 year follow-up

Other Outcomes

Description: how many modules each individual completes, with less than 2 being considered dropout

Measure: completion rate of modules

Time: 6 weeks

No related HPO nodes (Using clinical trials)